recombinant CD40-ligand

BIOLOGICAL3 trials

Sponsors

University of Southern California, National Cancer Institute (NCI), University Hospital Erlangen

Conditions

Kidney CancerMelanoma (Skin)

Phase 1

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

CompletedNCT00053391

University Hospital ErlangenMelanoma (Skin)

Start: 2002-10-31End: 2007-06-30Updated: 2015-05-12

Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

CompletedNCT00020540

National Cancer Institute (NCI)Kidney Cancer, Melanoma (Skin)

Start: 2001-03-31Updated: 2015-04-30

Phase 2

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

TerminatedNCT00006113

University of Southern CaliforniaMelanoma (Skin)

Start: 1999-06-30End: 2006-04-30Updated: 2014-05-22

Related Papers

Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.

2017-04-2062 citations